Erlotinib protests against LPS-induced parthanatos through inhibiting macrophage surface TLR4 expression

• Main Authors: Qiong Xue, Xiaolei Liu, Cuiping Chen, Xuedi Zhang, Pengyun Xie, Yupin Liu, Shuangnan Zhou, Jing Tang
• Format: Article
• Language: English
• Published: Nature Publishing Group 2021-07-01
• Series: Cell Death Discovery
• Online Access: https://doi.org/10.1038/s41420-021-00571-4

Abstract Sepsis is a life-threatening cascading systemic inflammatory response syndrome on account of serve infection. In inflamed tissues, activated macrophages generate large amounts of inflammatory cytokines reactive species, and are exposed to the damaging effects of reactive species. However, comparing with necroptosis and pyroptosis, so far, there are few studies focusing on the overproduction-related cell death, such as parthanatos in macrophage during sepsis. In LPS-treated macrophage, we observed PARP-1 activation, PAR formation and AIF translocation. All these phenomena could be inhibited by both erlotinib and 3-AB, indicating the presence of parthanatos in endotoxemia. We further found that LPS induced the increase of cell surface TLR4 expression responsible for the production of ROS and subsequent parthanatos in endotoxemia. All these results shed a new light on how TLR4 regulating the activation of PARP-1 by LPS in macrophage.